VAM
ABBV icon

Visium Asset Management’s AbbVie ABBV Stock Holding History

Visium Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-429
Closed -$8K – 881
2015
Q2 		$8K Buy
+429
New +$28K ﹤0.01% 1104

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Visium Asset Management's ABBV Position: Q4 2015 in Review

Visium Asset Management sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 159,691 shares — an estimated $8.69M sold.

Visium Asset Management first reported a position in ABBV in Q2 2014 and held it in 4 quarters. The position peaked at $8.69M in Q3 2015. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • Visium Asset Management reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
  • Visium Asset Management sold 159,691 AbbVie shares in Q4 2015, an estimated $8.69M.
  • Visium Asset Management first reported a position in AbbVie in Q2 2014 and held it in 4 quarters.
  • Visium Asset Management's AbbVie position peaked at $8.69M in Q3 2015.
  • 1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.